20527 ⎘
Medicinal preparations containing organic active ingredients; Carbohydrates; Sugars; Derivatives thereof; Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
Sub-classes:RECOMBINANT APYRASE PROTEIN FOR USE IN THE TREATMENT OF AN ISCHEMIC EVENT AT A DOSE OF 40-240 MG
#2ANTIVIRAL PRODRUGS, INTERMEDIATE-AND LONG-ACTING FORMULATIONS AND METHODS
#3MODULATORS OF 5'-NUCLEOTIDASE, ECTO AND THE USE THEREOF
#4METHODS AND COMPOSITIONS FOR INHIBITION OF POLYMERASE
#5TREATMENT OF ONCOGENE-DRIVEN CANCERS
#6METHODS TO TREAT NEURODEGENERATIVE DISORDERS BY REDUCING NUCLEAR AGGREGATES AND MODULATING ADENOSINE-TO-INOSINE RNA EDITING
#7OVARIAN CANCER VACCINES
#8ANTI-PD-L1 COMBINATIONS FOR TREATING TUMORS
#9NUCLEOSIDE LINE-1 INHIBITORS
#10TARGETING CHROMATIN REGULATORS INHIBITS LEUKEMOGENIC GENE EXPRESSION IN NPM1 MUTANT LEUKEMIA
#11SARS-COV-2 NSP14 METHYLTRANSFERASE INHIBITORS
#12PROCESSES FOR MAKING PRMT5 INHIBITORS
#13Nucleoside Analogues for the Treatment of Parasitic Infections
#14INHIBITORS OF ADENOSINE 5'-NUCLEOTIDASE
#15NOVEL PYRROLOPYRIMIDINONE CARBOXAMIDE COMPOUND FOR INHIBITING CDK, STEREOISOMER THEREOF OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION FOR TREATING CANCER, COMPRISING SAME AS ACTIVE INGREDIENT
#16PHARMACEUTICAL COMPOSITION FOR TREATING CANCER
#17SPECIFIC SMALL MOLECULE INHIBITORS THAT BLOCK KMT9 METHYLTRANSFERASE ACTIVITY AND FUNCTION
#18ANTIVIRAL PRODRUGS, INTERMEDIATE-AND LONG-ACTING FORMULATIONS AND METHODS
#19PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING WET AGE-RELATED MACULAR DEGENERATION
#20Pyrimidinone-Containing 17-Beta-Hydroxysteroid Dehydrogenase Type 13 Inhibitors
#216-SUBSTITUTED- AND 6,7-DISUBSTITUTED-7-DEAZAPURINE RIBONUCLEOSIDE ANALOGUES
#22FLEX-NUCLEOSIDE ANALOGUES, NOVEL THERAPEUTICS AGAINST VIRUSES
#23PYRROLOPYRIMIDINE NUCLEOSIDES AND ANALOGS THEREOF
#24COMPOUNDS AND METHODS FOR TREATING OR PREVENTING AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD), AUTOSOMAL DOMINANT POLYCYSTIC LIVER DISEASE (ADPLD) AND/OR AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE (ARPKD)
#25GLYCOMIMETIC BINDERS FOR L-SIGN
#26ADMINISTRATION OF NICOTINAMIDE MONONUCLEOTIDE IN THE TREATMENT OF DISEASE
#27MUTATIONAL MARKERS IN PANCREATIC NEUROENDOCRINE TUMORS FOR USE IN STRATIFYING RESPONSE TO CAPECITABINE/TEMOZOLOMIDE
#28POLY AMPHIPHILIC COMPLEXES FOR THE DELIVERY OF A HYDROPHOBIC ACTIVE AGENT, COMPOSITIONS AND METHODS
#29SMALL MOLECULAR CD73 ANTAGONIST AND USE THEREOF
#30MODULATORS OF 5'-NUCLEOTIDASE, ECTO AND THE USE THEREOF
#31NUCLEOSIDE DERIVATIVE HAVING MULTI-TARGET KINASE INHIBITORY ACTIVITY AND PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING CANCER COMPRISING SAME
#32PRODRUGS OF 4'-SUBSTITUTED NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS
#33Inhibitors of adenosine 5′-nucleotidase
#34COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF CORONAVIRUS AND RELATED DISORDERS
#35PROTEOLYSIS TARGETING COMPOUND WITH TISSUE TARGETING CAPABILITY AND USE THEREOF
#36HIGHLY ACTIVE COMPOUNDS AGAINST COVID-19
#37Highly active compounds against COVID-19
#38MODIFIED NUCLEOSIDES AND NUCLEOTIDES ANALOGS AS ANTIVIRAL AGENTS FOR CORONA AND OTHER VIRUSES
#39Methods of Producing Improved Immune Cell Populations
#40TRANSDERMAL PENETRANT FORMULATIONS FOR ADMINISTRATION OF MEDICAMENTS
#41Antiviral Agents and Nucleoside Analogs for Treatment of Zika Virus
#42PYRROLOPYRIMIDINE NUCLEOSIDES FOR TREATING OR PREVENTING A SARS-COV-2 INFECTION
#43Nucleoside phosphoramidate prodrugs
#44ANTI-VIRAL AGENT
#45TRANSDERMAL PENETRANT FORMULATIONS FOR ADMINISTRATION OF MEDICAMENTS
#46METHODS FOR TREATING AND AMELIORATING CANCER
#47DIAGNOSIS AND THERAPY OF CANCER INVOLVING CANCER STEM CELLS
#48OVARIAN CANCER VACCINES
#49Administration of nicotinamide mononucleotide in the treatment of disease
#50METHOD FOR TREATING ARENAVIRIDAE INFECTIONS
#51Methods Of Treating Cancer Using Prmt5 Inhibitors
#52Cysteine protease inhibitors and methods of use thereof
#53METHOD FOR TREATING POXVIRIDAE INFECTIONS
#54COMPOSITIONS AND METHODS FOR TREATING HYPERGLYCEMIA IN TYPE-2 DIABETES
#55Compositions and methods for treating retinal degradation
#56USE OF NICOTINAMIDE RIBOSIDE, NICOTINIC ACID RIBOSIDE, AND NICOTINAMIDE MONONUCLEOTIDE, REDUCED NICOTINYL COMPOUNDS, AND NICOTINOYL COMPOUND DERIVATIVES IN INFANT FORMULA FOR HEALTHY DEVELOPMENT
#57USE OF A COMPOUND OR COMPOSITION COMPRISING AN INHIBITOR OF NLRP1 INFLAMMASOME ACTIVATION FOR THE TREATMENT OF HUMAN AIRWAY INFLAMMATION
#58Method For Treating Pancreatic Cancer
#59METHODS, COMPOSITIONS, AND DOSING REGIMENS FOR TREATMENT OF SARS-COV-2 INFECTIONS
#60COMPOUNDS FOR TREATING OR PREVENTING A CORONAVIRIDAE INFECTION & METHODS AND USES FOR ASSESSING THE OCCURRENCE OF A CORONAVIRIDAE INFECTION
#61COMPOSITIONS AND METHODS CONTAINING REDUCED NICOTINAMIDE RIBOSIDE FOR PREVENTION AND TREATMENT OF NEUROLOGICAL DISEASES AND CONDITIONS
#62NOVEL 6-SUBSTITUTED 7-DEAZAPURINES AND CORRESPONDING NUCLEOSIDES AS MEDICAMENTS
#63COMPOSITIONS AND METHODS CONTAINING REDUCED NICOTINAMIDE RIBOSIDE FOR PREVENTION AND TREATMENT OF LUNG DISEASES AND CONDITIONS
#64METHODS FOR PREVENTION OR TREATMENT OF VIRUS-INDUCED ORGAN INJURY OR FAILURE WITH IL-22 DIMER
#65AKT INHIBITORS FOR ENHANCING CHIMERIC T CELL PERSISTENCE
#66COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS
#67URIDINE DIPHOSPHATE DERIVATIVES, PRODRUGS, COMPOSITIONS AND USES THEREOF
#68Antiviral agents and nucleoside analogs for treatment of Zika virus
#69COMBINATION THERAPY WITH PROTEIN KINASE B ACTIVATION INHIBITOR TO TREAT CANCER
#70Method for treating coronavirus infections
#71Highly active compounds against COVID-19
#72Highly active compounds against COVID-19
#73Methods And Compositions For Treating Viral Diseases Using Combination Of Drugs
#74METHODS FOR TREATING COVID-19 BASED ON INDIVIDUAL GENOMIC PROFILES
#75ENHANCING THE ANTIVIRAL EFFICACY OF RNA VIRUS INHIBITION BY COMBINATION WITH MODULATORS OF PYRIMIDINE METABOLISM
#76CD73 INHIBITORS
#77ANTI-PD-L1 COMBINATIONS FOR TREATING TUMORS
#78Compositions and methods for preserving red blood cells and platelets
#79TREATMENT OF ONCOGENE-DRIVEN CANCERS
#80NOVEL CARBONATE COMPOUND HAVING PYRROLOPYRIMIDINE SKELETON OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
#81Selective Inhibitors Of Protein Arginine Methyltransferase 5 (PRMT5)
#82METHODS FOR MODULATING CHEMOTHERAPEUTIC CYTOTOXICITY
#83TAZ ACTIVATORS AND WNT AGONISTS FOR TREATING EAR DISORDERS
#84Selective Inhibitors Of Protein Arginine Methytransterase 5 (PRMT5)
#85Selective Inhibitors Of Protein Arginine Methyltransferase 5 (PRMT5)
#86Selective Inhibitors Of Protein Arginine Methyltransferase 5 (PRMT5)
#87URIDINE NUCLEOSIDE DERIVATIVES, COMPOSITIONS AND METHODS OF USE
#88Mannose derivatives for treating bacterial infections
#89Compounds and methods useful for treating or preventing cancers
#90Compositions and methods for enhanced delivery of antiviral agents
#91Madrasin-derivative compounds, composition and uses thereof for treating cancer
#92Methods and Compositions for Inhibition of Polymerase
#93METHODS OF TREATING CANCER WITH FARNESYLTRANSFERASE INHIBITORS
#94Pyrrolopyrimidine nucleosides and analogs thereof
#95PHARMACEUTICAL FORMULATION CONTAINING ACTIVE METABOLITES OF REMDESIVIR OR ITS ANALOG FOR INHALATION
#96Ovarian cancer vaccines
#97Combination of low dose IL-2 and an inhibitor of Treg IL-2R desensitization to treat autoimmune and allergic inflammatory diseases
#98Modulators of 5′-nucleotidase, ecto and the use thereof
#99Administration of nicotinamide mononucleotide in the treatment of disease
#100Multi-component injection
#101METHOD OF MAKING SOLANACEAE FRUIT EXTRACTS
#102Highly active compounds against COVID-19
#103SUBSTITUTED PURINE AND 7-DEAZAPURINE COMPOUNDS
#104Method for treating coronavirus infections
#105Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development
#106Use Of Stearic Acid For Preventing Or Treating Pulmonary Fibrosis
#107Nucleoside phosphoramidate prodrugs
#1084'-SUBSTITUTED NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS AND PREPARATIONS THEREOF
#109Methods and agents for modulating inflammation
#110COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS
#111Substituted nucleosides, nucleotides and analogs thereof
#112Compositions and methods for treating retinal degradation
#113Uridine diphosphate derivatives, prodrugs, compositions and uses thereof
#114ANTIVIRAL COMPOUNDS
#115Persistent topical antimicrobial compositions and methods of using the same
#116Methods of treating cancers overexpressing CARM1 with EZH2 inhibitors and a PARP inhibitor
#117REDUCING CUTANEOUS SCAR FORMATION AND TREATING SKIN CONDITIONS
#118Modulators of 5′-nucleotidase, ecto and the use thereof
#119Uridine nucleoside derivatives, compositions and methods of use
#120DIETARY SUPPLEMENT COMPOSITIONS FOR TREATING HYPERTENSION AND METHODS OF USING SAME FOR TREATING HYPERTENSION
#121Diagnosis and therapy of cancer involving cancer stem cells
#122HEPATITIS C ANTIVIRAL COMPOSITIONS AND METHODS
#123Methods of treating cancer using PRMT5 inhibitors
#124Compositions and methods for preserving red blood cells and platelets
#125Selective inhibitors of protein arginine methytransterase 5 (PRMT5)
#126Cancer therapeutic methods utilizing OPCML fragment
#127CD73 inhibitors
#128Substituted nucleoside analogues for use as PRMT5 inhibitors
#129Method of treating, reducing, or alleviating a medical condition in a patient
#130Tools for assessing FimH blockers therapeutic efficiency
#1312,7-dibromospiro[fluorene-9,4′-piperidine] compounds
#132PERK AND IRE-1A INHIBITORS AGAINST NEURODEVELOPMENTAL DISORDERS
#133Methods for the detection and treatment of leukemias that are responsive to DOT1L inhibition
#134CHEMOENZYMATIC SYNTHESIS OF S-NUCLEOSYL AMINO ACIDS (SNA), ANALOGS OF S-ADENOSYL-L-METHIONINE AND S-ADENOSYL-L- HOMOCYSTEINE AND USES THEREOF
#135PREVENTION AND TREATMENT OF CORONAVIRUS AND OTHER RESPIRATORY INFECTIONS USING NANOEMULSION COMPOSITIONS
#136Inhibitors of adenosine 5′-nucleotidase
#137Pyrrolopyrimidine nucleosides and analogs thereof
#138Methods of treating and inhibiting Ebola virus infection
#139Drug formulations
#140Selective inhibitors of protein arginine methlytransferase 5 (PRMT5)
#141DOT1L INHIBITORS FOR USE IN THE TREATMENT OF LEUKEMIA
#142ANTIVIRAL COMPOUNDS
#143Quantitative determination of nucleoside analogue drugs in genomic DNA or RNA
#144COMBINATION THERAPY FOR TREATING CANCER
#145Orally available compounds, a process for preparing the same and their uses as anti-adhesive drugs for treating induced inflammatory bowel diseases such as crohn's disease
#146Methods and compositions for inhibition of polymerase
#147Compositions and methods for preserving red blood cells and platelets
#148Methods of treating mitochondrial dysfunction
#149USE OF COMPOUNDS ACTIVATING SIRT-3 FOR MIMICKING EXERCISE
#150Modulators of 5′-nucleotidase, ecto and the use thereof
#151Targeting chromatin regulators inhibits leukemogenic gene expression in NPM1 mutant leukemia
#152DOT1L INHIBITION IN PATIENTS WITH MN1-HIGH AML
#153Antiviral compounds
#154A MULTI-COMPONENT INJECTION
#155Compositions and methods for treating retinal degradation
#156Cancer chemotherapy employing halogenated analogs of thymidine
#157Purine derivative for use in the treatment or prevention of diseases caused by a nonsense mutation
#158REDUCING CUTANEOUS SCAR FORMATION AND TREATING SKIN CONDITIONS
#159Administration of nicotinamide mononucleotide in the treatment of disease
#160DEUTERATED NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS
#161Ovarian cancer vaccines
#162Treatment of hippo pathway mutant tumors and methods of identifying subjects as candidates for treatment
#163Methods for improving cognitive function via modulation of quinone reductase 2
#164Mannose derivatives for treating bacterial infections
#165Treatment and prevention of anal conditions
#166INHIBITORS OF PROTEIN METHYLTRANSFERASE DOT1L AND METHODS OF USE THEREOF
#167Therapies for cardiomyopathy
#168Substituted nucleosides, nucleotides and analogs thereof
#169ANTI-PD-L1 COMBINATIONS FOR TREATING TUMORS
#170PREVENTION OF VASCULAR AND CARDIAC FIBROSIS VIA IRE1ALPHA INHIBITION
#171Compositions and methods for treating cancers
#172Thioether triazolopyridine and triazolopyrimidine inhibitors of myeloperoxidase
#173Carboline derivatives or phosphorous derivatives for the treatment of muscular myopathies and traumatic injuries to muscles
#1744′-Substituted nucleoside reverse transcriptase inhibitors and preparations thereof
#175Drug formulations
#176Methods and compositions for inhibition of polymerase
#177Compositions and methods for preserving red blood cells and platelets
#178HEATR1 as a marker for chemoresistance
#179Anti-PD-L1 combinations for treating tumors
#180NAD BIOSYNTHESIS AND PRECURSORS FOR THE TREATMENT AND PREVENTION OF CANCER AND PROLIFERATION
#181TARGETED THERAPEUTIC NUCLEOSIDES AND THEIR USE
#182SUBSTITUTED PURINE AND 7-DEAZAPURINE COMPOUNDS
#183Uridine diphosphate derivatives, prodrugs, compositions and uses thereof
#184Alkynyl nucleoside analogs as inhibitors of human rhinovirus
#185Method of making solanaceae fruit extracts
#186Cyclic di-nucleotide compounds as STING agonists
#187ANTIVIRAL COMPOUNDS
#188Cyclic di-nucleotide compounds as sting agonists
#189METHODS AND COMPOSITIONS FOR TREATING FLAVIVIRUSES AND PESTIVIRUSES
#190Cyclic di-nucleotide compounds as STING agonists
#191COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS
#192ANTIVIRAL COMPOUNDS
#193Substituted purine compounds
#194Synergistic enhancement of 5-fluorouracil cytotoxicity by deoxyuridine analogs in cancer cells
#195Solid dosage formulations of substituted quinazoline receptor-type kinase modulators and methods of use thereof
#196Macroheterocyclic nucleoside derivatives and their analogues, production and use thereof
#197Nucleoside agents for the reduction of the deleterious activity of extended nucleotide repeat containing genes
#198Administration of nicotinamide mononucleotide in the treatment of disease
#199Substituted nucleosides, nucleotides and analogs thereof
#200Treatment of ACVR1-mediated diseases
#201Cancer methods
#2024'-SUBSTITUTED NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS
#203Nucleoside phosphoramidate prodrugs
#204Combined treatment with a TLR7 agonist and an HBV capsid assembly inhibitor
#205HEPATITIS C ANTIVIRAL COMPOSITIONS AND METHODS
#206Methods of treating hepatitis E viral infection
#207INHIBITION OF NONSENSE MEDIATED MRNA DECAY BY DRUGS THAT PREVENT HYPUSINATION OF EUKARYOTIC INITIATION FACTOR 5A
#208MUTAGENIC NUCLEOSIDE ANALOGS AND USES THEREOF
#209Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development
#210Methods of treating breast cancer that overexpress AKT kinase
#211Alkynyl nucleoside analogs as inhibitors of human rhinovirus
#212Modulators of 5′-nucleotidase, ecto and the use thereof
#213Pyrrolopyrimidine nucleosides and analogs thereof
#214THIOETHER TRIAZOLOPYRIDINE AND TRIAZOLOPYRIMIDINE INHIBITORS OF MYELOPEROXIDASE
#2157-deazapurine nucleosides for therapeutic uses
#216COMBINATION THERAPY FOR TREATING CANCER
#217Cancer chemotherapy employing halogenated analogs of thymidine
#218Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof
#219Compounds antagonizing A3 adenosine receptor, method for preparing them, and medical-use thereof
#220Application of cyclic dinucleotide (cGAMP) in anti-tumor field
#221RNA EDITING BIOMARKERS FOR DIAGNOSIS, PHARMACOLOGICAL SCREENING AND PROGNOSTICATION IN CANCER
#222Antiviral composition containing material involved in phosphatidylcholine synthesis pathway
#223Substituted nucleosides, nucleotides and analogs thereof
#224Inhibitors of protein methyltransferase DOT1L and methods of use thereof
#225Pyrrolopyrimidine nucleosides and analogs thereof
#226UBA5 inhibitors
#227TRANSIENT INHIBITION OF ADENOSINE KINASE AS AN ANTI-EPILEPTOGENESIS TREATMENT
#228Gemcitabine analogs
#229Methods for improving cognitive function via modulation of quinone reductase 2
#230EFFECTIVE TREATMENT OF ESOPHAGEAL ADENOCARCINOMA USING TRICIRIBINE AND RELATED COMPOUNDS
#231Sofosbuvir in crystalline form and process for its preparation
#232Cyclic di-nucleotide compounds as sting agonists
#2333′-substituted methyl or alkynyl nucleosides nucleotides for the treatment of HCV
#234Effective treatment of ovarian cancer using triciribine and related compounds
#235Methods and compositions for inhibition of polymerase
#236External dermatological agent for anti-ageing
#237Nucleotides for the treatment of liver cancer
#238Substituted purine compounds
#239Compositions of selenoorganic compounds and methods of use thereof
#240Targeted therapeutic nucleosides and their use
#241Drug formulations
#242Orally available compounds, a process for preparing the same and their uses as anti-adhesive drugs for treating induced inflammatory bowel diseases such as crohn's disease
#2437-deazapurine nucleosides for therapeutic uses
#244Solid forms of a thiophosphoramidate nucleotide prodrug
#245Methods for the detection and treatment of leukemias that are responsive to DOT1L inhibition
#246Solid forms comprising 4-amino-1-β-D-ribofuranosyl-1,3,5-triazin-2(1H)-one and a coformer, compositions and methods of use thereof
#2472′,4′-substituted nucleosides as antiviral agents
#2485′-nucleotidase inhibitors and therapeutic uses thereof
#249USE OF COMPOUNDS ACTIVATING SIRT-3 FOR MIMICKING EXERCISE
#250Compositions and methods for treating retinal degradation
#251Substituted nucleoside derivatives useful as anticancer agents
#2522′, 5′-dideoxy-5-fluorouridine derivatives having cytotoxic activity, a process for the manufacture thereof and application thereof
#253Uridine diphosphate derivatives, prodrugs, compositions and methods for treating neurodegenerative disorders
#254Methods and Compositions for Targeting Tumor Microenvironment and for preventing Metastasis
#255Mannose derivatives for treating bacterial infections
#256Mutagenic nucleoside analogs and uses thereof
#257Uridine and uridine analogues for treatment of specific lung diseases, namely COPD and pulmonary fibrosis
#258Identification of small molecules that facilitate therapeutic exon skipping
#259Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof
#260Substituted nucleosides, nucleotides and analogs thereof
#261Therapeutic agent for inflammatory diseases, containing adenosine N1-oxide as an effective ingredient
#262Diagnosis and therapy of cancer involving cancer stem cells
#263Nucleoside and nucleotide derivatives
#264METHODS AND COMPOSITIONS FOR THE TREATMENT OF HISTIOCYTOSIS
#2652′ Fluoronucleosides
#266Compositions and methods for preserving donated blood
#267Targeting thymidine kinase photosensitizer and pharmaceutical composition and use for cancer treatment thereof
#268Compounds and methods for treating bacterial infections
#269Compositions including triciribine and trastuzumab and methods of use thereof
#270Compositions including triciribine and bortezomib and derivatives thereof and methods of use thereof
#271Deuterated nucleoside/tide derivatives
#272Substituted quinazolines as receptor-type kinase inhibitors
#273Cyclic phosphonate substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
#274PARASITICIDAL COMPOUNDS, METHODS, AND FORMULATIONS
#275THERAPIES FOR CARDIOMYOPATHY
#276Method for predicting therapeutic efficacy of PI3K/AKT/mTOR inhibitor on basis of PHLDA1 or PIK3C2B expression
#277Method for stimulating the intestinal flora
#278Indolin-2-one or pyrrolo-pyridin/pyrimidin-2-one derivatives
#279Compositions of selenoorganic compounds and methods of use thereof
#280Antitumor agent including low-dose irinotecan hydrochloride hydrate
#281Uridine nucleoside derivatives, compositions and methods of use
#282METHOD FOR STIMULATING INTESTINAL BARRIER INTEGRITY AFTER NON-NATURAL BIRTH
#283Nucleoside and nucleotide derivatives
#284Methods for modulating chemotherapeutic cytotoxicity
#285COMBINATION THERAPY FOR TREATING CANCER
#286Antitumor agent including irinotecan hydrochloride hydrate
#287Combination therapy for the treatment of proliferative diseases
#288Administration of nicotinamide mononucleotide in the treatment of disease
#289Compositions including triciribine and one or more platinum compounds and methods of use thereof
#290Dual-action compounds targeting adenosine Areceptor and adenosine transporter for prevention and treatment of neurodegenerative diseases
#291Combined systemic and topical treatment of disordered and/or prodromal stage tissue
#292SUBSTITUTED PURINE AND 7-DEAZAPURINE COMPOUNDS
#293Method using heat shock protein inhibitor for treating hepatitis and hepatoma
#294Effective treatment of esophageal adenocarcinoma using triciribine and related compounds
#295Methods and compositions for inducing deregulation of EPHA7 and ERK phosphorylation in human acute leukemias
#296DOT1L INHIBITORS FOR USE IN THE TREATMENT OF LEUKEMIA
#297Combined systemic and topical treatment of disordered tissues
#298Preventing diseases in infants delivered via caesarean section
#299Effective treatment of tumors and cancer with triciribine and related compounds
#300NAD biosynthesis and precursors for the treatment and prevention of cancer and proliferation